PubIndex
Search
Leaderboards
Bookmark
My Library
Sign in
Back
Cell Signaling Technology
PathScan® Total HER4/ErbB4 Sandwich ELISA Kit
#13010 · $661
100
Citing papers
6.4k
Combined citations
Copy product info
Export PDF dossier
Supplier page
Find this product
Research areas
Parkinson's Disease Mechanisms and Treatments
35
Alzheimer's disease research and treatments
16
Autophagy in Disease and Therapy
13
Neurological disorders and treatments
7
Heat shock proteins research
5
Cellular transport and secretion
5
Nerve injury and regeneration
5
Muscle Physiology and Disorders
5
Papers citing this product
1
Cell-Produced α-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival
Journal of Neuroscience
·
2010
·
1.1k cit.
·
DOI
2
Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies
Journal of Biological Chemistry
·
2010
·
877 cit.
·
DOI
3
Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia
Nature Communications
·
2013
·
838 cit.
·
DOI
4
Endoplasmic Reticulum Stress Is Important for the Manifestations of α-Synucleinopathy<i>In Vivo</i>
Journal of Neuroscience
·
2012
·
377 cit.
·
DOI
5
Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission
Journal of Neuroscience
·
2012
·
332 cit.
·
DOI
6
Autophagic failure promotes the exocytosis and intercellular transfer of α-synuclein
Experimental & Molecular Medicine
·
2013
·
201 cit.
·
DOI
7
Induction of Intracellular Tau Aggregation Is Promoted by α-Synuclein Seeds and Provides Novel Insights into the Hyperphosphorylation of Tau
Journal of Neuroscience
·
2011
·
199 cit.
·
DOI
8
Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein
Nature Communications
·
2014
·
179 cit.
·
DOI
9
Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy
PLoS ONE
·
2011
·
139 cit.
·
DOI
10
Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy
Molecular Neurodegeneration
·
2012
·
120 cit.
·
DOI
Show 90 more papers
Feedback